{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:39:18Z","timestamp":1791805158387,"version":"4.3.4"},"reference-count":59,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006832","name":"Center for HIV\/AIDS Educational Studies and Training, Hunter College","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006832","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.chest.2018.10.027","type":"journal-article","created":{"date-parts":[[2018,11,4]],"date-time":"2018-11-04T09:35:31Z","timestamp":1541324131000},"page":"825-833","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Bronchiectasis"],"prefix":"10.1016","volume":"155","author":[{"given":"Pamela J.","family":"McShane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Tino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chest.2018.10.027_bib1","unstructured":"Laennec RTH. On mediate auscultation, or a treatise on the diagnosis of diseases of the lungs and heart. Paris: J.-A. Broson et J.-S\u00a0Chaude; 1819."},{"issue":"3","key":"10.1016\/j.chest.2018.10.027_bib2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1136\/thx.7.3.213","article-title":"A\u00a0study of the pathology and pathogenesis of bronchiectasis","volume":"7","author":"Whitwell","year":"1952","journal-title":"Thorax"},{"issue":"12","key":"10.1016\/j.chest.2018.10.027_bib3","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1183\/09031936.97.10122784","article-title":"Bronchiectasis: an orphan disease with a poorly-understood prognosis","volume":"10","author":"Keistinen","year":"1997","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.chest.2018.10.027_bib4","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/S2213-2600(13)70005-5","article-title":"Bronchiectasis: breaking the cycle of inflammation and infection","volume":"1","author":"Mandal","year":"2013","journal-title":"Lancet Respir Med"},{"issue":"7","key":"10.1016\/j.chest.2018.10.027_bib5","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1164\/rccm.201203-0487OC","article-title":"Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis","volume":"186","author":"Chalmers","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"9842","key":"10.1016\/j.chest.2018.10.027_bib6","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0140-6736(12)60953-2","article-title":"Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial","volume":"380","author":"Wong","year":"2012","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.chest.2018.10.027_bib7","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1001\/jama.2013.1937","article-title":"Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial","volume":"309","author":"Altenburg","year":"2013","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.chest.2018.10.027_bib8","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1001\/jama.2013.2290","article-title":"Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial","volume":"309","author":"Serisier","year":"2013","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.chest.2018.10.027_bib9","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1136\/thoraxjnl-2013-203207","article-title":"Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial","volume":"68","author":"Serisier","year":"2013","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.chest.2018.10.027_bib10","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02052-2017","article-title":"RESPIRE 1: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis","volume":"51","author":"De Soyza","year":"2018","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.chest.2018.10.027_bib11","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02053-2017","article-title":"RESPIRE 2: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis","volume":"51","author":"Aksamit","year":"2018","journal-title":"Eur Respir J"},{"issue":"12","key":"10.1016\/j.chest.2018.10.027_bib12","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S2213-2600(14)70213-9","article-title":"The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial","volume":"2","author":"Rogers","year":"2014","journal-title":"Lancet Respir Med"},{"issue":"5","key":"10.1016\/j.chest.2018.10.027_bib13","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1164\/rccm.201309-1575OC","article-title":"The Bronchiectasis Severity Index: an international derivation and validation study","volume":"189","author":"Chalmers","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.chest.2018.10.027_bib14","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1183\/09031936.00026313","article-title":"Multidimensional approach to non-cystic fibrosis bronchiectasis: the FACED score","volume":"43","author":"Martinez-Garcia","year":"2014","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.chest.2018.10.027_bib15","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.chest.2016.10.055","article-title":"Adult patients with bronchiectasis: a first look at the US Bronchiectasis Research Registry","volume":"151","author":"Aksamit","year":"2017","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.chest.2018.10.027_bib16","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00081-2015","article-title":"The EMBARC European Bronchiectasis Registry: protocol for an international observational study","volume":"2","author":"Chalmers","year":"2016","journal-title":"ERJ Open Res"},{"issue":"3","key":"10.1016\/j.chest.2018.10.027_bib17","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1183\/20734735.005117","article-title":"The European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC): experiences from a successful ERS Clinical Research Collaboration","volume":"13","author":"Chalmers","year":"2017","journal-title":"Breathe (Sheff)"},{"issue":"6","key":"10.1016\/j.chest.2018.10.027_bib18","doi-asserted-by":"crossref","first-page":"1700051","DOI":"10.1183\/13993003.00051-2017","article-title":"Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research","volume":"49","author":"Hill","year":"2017","journal-title":"Eur Respir J"},{"issue":"spec iss","key":"10.1016\/j.chest.2018.10.027_bib19","first-page":"3","article-title":"Diagnosis, assessment, and phenotyping of COPD: beyond FEV(1)","volume":"11","author":"Lange","year":"2016","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.chest.2018.10.027_bib20","doi-asserted-by":"crossref","DOI":"10.1111\/cea.13170","article-title":"Prospective predictors of exacerbation status in severe asthma over a 3-year follow-up","author":"Kimura","year":"2018","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.chest.2018.10.027_bib21","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.201711-2202OC","article-title":"Characterisation of the \u201cfrequent exacerbator phenotype\u201d in bronchiectasis","author":"Chalmers","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.chest.2018.10.027_bib22","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.201802-0211ED","article-title":"Bronchiectasis: phenotyping an orphan disease","author":"Tino","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.chest.2018.10.027_bib23","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1183\/13993003.01899-2015","article-title":"Clinical phenotypes in adult patients with bronchiectasis","volume":"47","author":"Aliberti","year":"2016","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.chest.2018.10.027_bib24","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1183\/13993003.01888-2015","article-title":"Research priorities in bronchiectasis: a consensus statement from the EMBARC Clinical Research Collaboration","volume":"48","author":"Aliberti","year":"2016","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.chest.2018.10.027_bib25","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1183\/13993003.01312-2015","article-title":"Predicting mortality in bronchiectasis using Bronchiectasis Severity Index and FACED scores: a 19-year cohort study","volume":"47","author":"Ellis","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.chest.2018.10.027_bib26","first-page":"6","article-title":"Inflammation: a two-edged sword\u2014the model of bronchiectasis","volume":"147","author":"Cole","year":"1986","journal-title":"Eur J Respir Dis Suppl"},{"issue":"3","key":"10.1016\/j.chest.2018.10.027_bib27","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00629-2017","article-title":"European Respiratory Society guidelines for the management of adult bronchiectasis","volume":"50","author":"Polverino","year":"2017","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.chest.2018.10.027_bib28","doi-asserted-by":"crossref","first-page":"130","DOI":"10.5694\/mjac14.00287","article-title":"Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand Thoracic Society of Australia and New Zealand guidelines","volume":"202","author":"Chang","year":"2015","journal-title":"Med J Aust"},{"key":"10.1016\/j.chest.2018.10.027_bib29","article-title":"Spanish guidelines on treatment of bronchiectasis in adults","author":"Martinez-Garcia","year":"2017","journal-title":"Arch Bronconeumol"},{"issue":"suppl 1","key":"10.1016\/j.chest.2018.10.027_bib30","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/thx.2010.136119","article-title":"British Thoracic Society Bronchiectasis non-CF Guideline Group. British Thoracic Society guideline for non-CF bronchiectasis","volume":"65","author":"Pasteur","year":"2010","journal-title":"Thorax"},{"issue":"6","key":"10.1016\/j.chest.2018.10.027_bib31","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/resp.13106","article-title":"The past decade in bench research into pulmonary infectious diseases: what do clinicians need to know?","volume":"22","author":"Finch","year":"2017","journal-title":"Respirology"},{"issue":"8","key":"10.1016\/j.chest.2018.10.027_bib32","doi-asserted-by":"crossref","first-page":"e0183553","DOI":"10.1371\/journal.pone.0183553","article-title":"Differences of lung microbiome in patients with clinically stable and exacerbated bronchiectasis","volume":"12","author":"Byun","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.chest.2018.10.027_bib33","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1164\/rccm.200703-417OC","article-title":"Airway bacterial concentrations and exacerbations of chronic obstructive pulmonary disease","volume":"176","author":"Sethi","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.chest.2018.10.027_bib34","doi-asserted-by":"crossref","first-page":"e0170622","DOI":"10.1371\/journal.pone.0170622","article-title":"Longitudinal assessment of sputum microbiome by sequencing of the 16S rRNA gene in non-cystic fibrosis bronchiectasis patients","volume":"12","author":"Cox","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.chest.2018.10.027_bib35","article-title":"Molecular epidemiology of Pseudomonas aeruginosa in an unsegregated bronchiectasis cohort sharing hospital facilities with a cystic fibrosis cohort","author":"Mitchelmore","year":"2017","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.chest.2018.10.027_bib36","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01937-2017","article-title":"Cross-infection risk in patients with bronchiectasis: a position statement from the European Bronchiectasis Network (EMBARC), EMBARC\/ELF patient advisory group and European Reference Network (ERN-Lung) Bronchiectasis Network","volume":"51","author":"Chalmers","year":"2018","journal-title":"Eur Respir J"},{"issue":"11","key":"10.1016\/j.chest.2018.10.027_bib37","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1513\/AnnalsATS.201506-333OC","article-title":"A\u00a0comprehensive analysis of the impact of Pseudomonas aeruginosa colonization on prognosis in adult bronchiectasis","volume":"12","author":"Finch","year":"2015","journal-title":"Ann Am Thorac Soc"},{"issue":"4","key":"10.1016\/j.chest.2018.10.027_bib38","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02108-2016","article-title":"Pseudomonas aeruginosa adaptation and diversification in the non-cystic fibrosis bronchiectasis lung","volume":"49","author":"Hilliam","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.chest.2018.10.027_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rmed.2017.05.001","article-title":"Anti-Pseudomonas aeruginosa IgG antibodies and chronic airway infection in bronchiectasis","volume":"128","author":"Suarez-Cuartin","year":"2017","journal-title":"Respir Med"},{"issue":"8","key":"10.1016\/j.chest.2018.10.027_bib40","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1164\/rccm.201312-2208OC","article-title":"Inhaled colistin in patients with bronchiectasis and chronic Pseudomonas aeruginosa infection","volume":"189","author":"Haworth","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.chest.2018.10.027_bib41","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S2213-2600(14)70165-1","article-title":"Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials","volume":"2","author":"Barker","year":"2014","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.chest.2018.10.027_bib42","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.cct.2017.05.007","article-title":"The RESPIRE trials: two phase III, randomized, multicentre, placebo-controlled trials of ciprofloxacin dry powder for inhalation (ciprofloxacin DPI) in non-cystic fibrosis bronchiectasis","volume":"58","author":"Aksamit","year":"2017","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.chest.2018.10.027_bib43","first-page":"A7604","article-title":"Inhaled liposomal ciprofloxacin in patients with bronchiectasis and chronic Pseudomonas aeruginosa infection: results from two parallel phase III trials (ORBIT-3 and -4)","volume":"195","author":"Haworth","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.chest.2018.10.027_bib44","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02444-2017","article-title":"RESPIRE: breathing new life into bronchiectasis","volume":"51","author":"Chotirmall","year":"2018","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.chest.2018.10.027_bib45","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.pharmthera.2014.03.003","article-title":"Azithromycin: mechanisms of action and their relevance for clinical applications","volume":"143","author":"Parnham","year":"2014","journal-title":"Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.chest.2018.10.027_bib46","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.drup.2012.04.001","article-title":"Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria","volume":"15","author":"van Ingen","year":"2012","journal-title":"Drug Resist Updat"},{"issue":"3","key":"10.1016\/j.chest.2018.10.027_bib47","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.rmed.2013.09.014","article-title":"Nontuberculous mycobacterial (NTM) lung disease: the top ten essentials","volume":"108","author":"Aksamit","year":"2014","journal-title":"Respir Med"},{"issue":"12","key":"10.1016\/j.chest.2018.10.027_bib48","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/82219","article-title":"Statins as a newly recognized type of immunomodulator","volume":"6","author":"Kwak","year":"2000","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.chest.2018.10.027_bib49","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1164\/rccm.200810-1584OC","article-title":"Simvastatin decreases lipopolysaccharide-induced pulmonary inflammation in healthy volunteers","volume":"179","author":"Shyamsundar","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.chest.2018.10.027_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2008.06.030","article-title":"Prior statin use is associated with improved outcomes in community-acquired pneumonia","volume":"121","author":"Chalmers","year":"2008","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.chest.2018.10.027_bib51","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S2213-2600(14)70050-5","article-title":"Atorvastatin as a stable treatment in bronchiectasis: a randomised controlled trial","volume":"2","author":"Mandal","year":"2014","journal-title":"Lancet Respir Med"},{"issue":"2","key":"10.1016\/j.chest.2018.10.027_bib52","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.chest.2017.05.017","article-title":"A\u00a0randomized controlled trial of atorvastatin in patients with bronchiectasis infected with Pseudomonas aeruginosa: a proof of concept study","volume":"152","author":"Bedi","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.chest.2018.10.027_bib53","doi-asserted-by":"crossref","DOI":"10.1002\/cpt.1053","article-title":"Dipeptidyl peptidase 1 inhibitor AZD7986 induces a sustained, exposure-dependent reduction in neutrophil elastase activity in healthy subjects","author":"Palmer","year":"2018","journal-title":"Clin Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.chest.2018.10.027_bib54","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1164\/rccm.201605-1027OC","article-title":"Neutrophil elastase activity is associated with exacerbations and lung function decline in bronchiectasis","volume":"195","author":"Chalmers","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.chest.2018.10.027_bib55","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.chest.2017.03.056","article-title":"The role of neutrophil elastase inhibitors in lung diseases","volume":"152","author":"Polverino","year":"2017","journal-title":"Chest"},{"issue":"1065","key":"10.1016\/j.chest.2018.10.027_bib56","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1136\/bmj.1.1065.837","article-title":"Lectures on bronchiectasis","volume":"1","author":"Williams","year":"1881","journal-title":"Br Med J"},{"key":"10.1016\/j.chest.2018.10.027_bib57","doi-asserted-by":"crossref","first-page":"160086","DOI":"10.1183\/16000617.0086-2016","article-title":"Personalising airway clearance in chronic lung disease","volume":"26","author":"McIlwaine","year":"2017","journal-title":"Eur Respir Rev"},{"issue":"11","key":"10.1016\/j.chest.2018.10.027_bib58","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1157\/13128330","article-title":"Diagnosis and treatment of bronchiectasis: Spanish Society of Pneumology and Thoracic Surgery","volume":"44","author":"Vendrell","year":"2008","journal-title":"Arch Bronconeumol"},{"issue":"1","key":"10.1016\/j.chest.2018.10.027_bib59","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01926-2017","article-title":"Long-term benefits of airway clearance in bronchiectasis: a randomised placebo-controlled trial","volume":"51","author":"Munoz","year":"2018","journal-title":"Eur Respir J"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369218327053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369218327053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T23:24:21Z","timestamp":1775258661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369218327053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0012369218327053"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2018.10.027","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bronchiectasis","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2018.10.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}